BMS-Celgene mega-merger receives shareholder nod
The $74bn deal appeared to be fraying around edges, as certain shareholders voiced dissent, but a vote saw the deal pass with support from more than 75% of investors.
Archives for April 15, 2019
Marken launches container for cell and gene therapy shipment
Marken introduces a container for shipments of clinical drug products, clinical drug substance, as well as cell and gene therapies.
Charles River extends Huntington’s Disease collaboration, shutters site in San Diego
Charles River Laboratories has extended its ongoing collaboration with the CHDI Foundation by five-years – and is closing its San Diego, CA-based research model production facility.
Trial app gives a ‘complete picture’ through passive data collection
monARC Bionetworks' new app enables patients to track symptoms between clinic visits – while also passively collecting environmental data, such as location and air quality.
Boehringer acquires ICD to ease biologic delivery
Boehringer acquires rights to ICD Therapeutics and its biologics-delivery platform for the development of oncology and immune oncology compounds.
FDA’s project uses RWE to estimate trial results
The FDA is advancing its project designed to determine the scientific validity and regulatory application of real-world evidence.
Automated chain-of-custody systems save $1.3m per clinical trial: Almac
Using automated chain-of-custody systems can save study sponsors and CROs a minimum of $1.3m per clinical trial in operating costs, according to a recent report from Almac.